Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Approaching Shared Pathophysiology in Immune-Mediated Diseases through Functional Genomics. | Genes (Basel) | 2020 | 33317201 | PubTator, text mining | PubMed |
| The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). | Clin Diabetes Endocrinol | 2020 | 33292863 | PubTator, text mining | PubMed |
| Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer. | Int J Mol Sci | 2020 | 33291786 | PubTator, text mining | PubMed |
| Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK. | Int J Mol Sci | 2020 | 33291717 | PubTator, text mining | PubMed |
| Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage. | Biomolecules | 2020 | 33291347 | PubTator, text mining | PubMed |
| Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development. | Cell | 2020 | 33275901 | PubTator, text mining | PubMed |
| Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature. | Haematologica | 2020 | 33256378 | PubTator, text mining | PubMed |
| Type I interferon in the pathogenesis of systemic lupus erythematosus. | Curr Opin Immunol | 2020 | 33246136 | PubTator, text mining | PubMed |
| Biallelic mutations in LAMA5 disrupts a skeletal noncanonical focal adhesion pathway and produces a distinct bent bone dysplasia. | EBioMedicine | 2020 | 33242826 | PubTator, text mining | PubMed |
| Bioinformatics for The Prognostic Value and Function of Cubilin (CUBN) in Colorectal Cancer. | Med Sci Monit | 2020 | 33235183 | PubTator, text mining | PubMed |
| Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia. | Int J Mol Sci | 2020 | 33233470 | PubTator, text mining | PubMed |
| Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report. | BMC Infect Dis | 2020 | 33228556 | PubTator, text mining | PubMed |
| Application of adipose-derived stem cells in photoaging: basic science and literature review. | Stem Cell Res Ther | 2020 | 33225962 | PubTator, text mining | PubMed |
| Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. | Blood Cancer Discov | 2020 | 33225311 | PubTator, text mining | PubMed |
| Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. | Cancers (Basel) | 2020 | 33217941 | PubTator, text mining | PubMed |
| Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases. | Int J Mol Sci | 2020 | 33213062 | PubTator, text mining | PubMed |
| Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers. | Int J Mol Sci | 2020 | 33198323 | PubTator, text mining | PubMed |
| Kawasaki Disease and COVID-19. | Mediterr J Rheumatol | 2020 | 33196004 | PubTator, text mining | PubMed |
| Cis- and Trans-Acting Expression Quantitative Trait Loci of Long Non-Coding RNA in 2,549 Cancers With Potential Clinical and Therapeutic Implications. | Front Oncol | 2020 | 33194770 | PubTator, text mining | PubMed |
| Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma. | Biomed Res Int | 2020 | 33178836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=45